447 related articles for article (PubMed ID: 28364255)
1. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
[TBL] [Abstract][Full Text] [Related]
2. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
Castoldi G; di Gioia CR; Bombardi C; Maestroni S; Carletti R; Steckelings UM; Dahlöf B; Unger T; Zerbini G; Stella A
Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1123-31. PubMed ID: 25186297
[TBL] [Abstract][Full Text] [Related]
3. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy.
Zhang Y; Zhao S; Wu D; Liu X; Shi M; Wang Y; Zhang F; Ding J; Xiao Y; Guo B
J Diabetes Res; 2018; 2018():4728645. PubMed ID: 29850604
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.
Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X
Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287
[TBL] [Abstract][Full Text] [Related]
6. Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.
Cheng Y; Wang D; Wang F; Liu J; Huang B; Baker MA; Yin J; Wu R; Liu X; Regner KR; Usa K; Liu Y; Zhang C; Dong L; Geurts AM; Wang N; Miller SS; He Y; Liang M
J Am Soc Nephrol; 2020 Jul; 31(7):1539-1554. PubMed ID: 32487559
[TBL] [Abstract][Full Text] [Related]
7. Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice.
Wang J; Gao Y; Ma M; Li M; Zou D; Yang J; Zhu Z; Zhao X
Cell Biochem Biophys; 2013 Nov; 67(2):537-46. PubMed ID: 23443810
[TBL] [Abstract][Full Text] [Related]
8. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.
Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z
Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506
[TBL] [Abstract][Full Text] [Related]
9. Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats.
Li Y; Qi Y; Kim MS; Xu KZ; Huang TH; Rong X; Murray M; Yamahara J
Diabetes Metab Res Rev; 2008 Sep; 24(6):498-506. PubMed ID: 18613221
[TBL] [Abstract][Full Text] [Related]
10. Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF-κB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells.
Zhang S; Xu L; Liang R; Yang C; Wang P
J Physiol Biochem; 2020 Aug; 76(3):407-416. PubMed ID: 32500512
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling.
Shi M; Tian P; Liu Z; Zhang F; Zhang Y; Qu L; Liu X; Wang Y; Zhou X; Xiao Y; Guo B
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484208
[TBL] [Abstract][Full Text] [Related]
12. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21.
Wu H; Kong L; Tan Y; Epstein PN; Zeng J; Gu J; Liang G; Kong M; Chen X; Miao L; Cai L
Diabetologia; 2016 Jul; 59(7):1558-1568. PubMed ID: 27115417
[TBL] [Abstract][Full Text] [Related]
13. Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
Liu Y; Li H; Liu J; Han P; Li X; Bai H; Zhang C; Sun X; Teng Y; Zhang Y; Yuan X; Chu Y; Zhao B
J Am Soc Nephrol; 2017 Dec; 28(12):3627-3638. PubMed ID: 28923913
[TBL] [Abstract][Full Text] [Related]
14. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1.
He F; Peng F; Xia X; Zhao C; Luo Q; Guan W; Li Z; Yu X; Huang F
Diabetologia; 2014 Aug; 57(8):1726-36. PubMed ID: 24908566
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice.
Kölling M; Kaucsar T; Schauerte C; Hübner A; Dettling A; Park JK; Busch M; Wulff X; Meier M; Scherf K; Bukosza N; Szénási G; Godó M; Sharma A; Heuser M; Hamar P; Bang C; Haller H; Thum T; Lorenzen JM
Mol Ther; 2017 Jan; 25(1):165-180. PubMed ID: 28129112
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-23b Targets Ras GTPase-Activating Protein SH3 Domain-Binding Protein 2 to Alleviate Fibrosis and Albuminuria in Diabetic Nephropathy.
Zhao B; Li H; Liu J; Han P; Zhang C; Bai H; Yuan X; Wang X; Li L; Ma H; Jin X; Chu Y
J Am Soc Nephrol; 2016 Sep; 27(9):2597-608. PubMed ID: 26839366
[TBL] [Abstract][Full Text] [Related]
17. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease.
Ma Z; Li L; Livingston MJ; Zhang D; Mi Q; Zhang M; Ding HF; Huo Y; Mei C; Dong Z
J Clin Invest; 2020 Sep; 130(9):5011-5026. PubMed ID: 32804155
[TBL] [Abstract][Full Text] [Related]
18. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.
Putta S; Lanting L; Sun G; Lawson G; Kato M; Natarajan R
J Am Soc Nephrol; 2012 Mar; 23(3):458-69. PubMed ID: 22223877
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy.
Bai X; Geng J; Zhou Z; Tian J; Li X
Sci Rep; 2016 Feb; 6():20475. PubMed ID: 26837280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]